Fundraising Fox
RNAiSSANCE AG
St. Louis, US · Founded 2018 · Delaware LLC · 2 known investors
Find your way into RNAiSSANCE AG
Sign up to see every warm intro you have to RNAiSSANCE AG
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RNAiSSANCE AG team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research. The company focuses on discovery and production of RNA interference technology for crop protection.
Founders & leadership
SM
Steve MeyerChief Executive OfficerSteve Meyer has over 20 years of experience in agricultural R&D, operations management, and systems improvement, with expertise in plant biology and genetics. He is Chief Executive Officer of RNAiSSANCE AG, which develops RNAi-based solutions for agricultural pest control.
BF
Brad FabbriNamed on SEC filing
MH
Michael HelmstetterNamed on SEC filing
BM
Brett MorrisNamed on SEC filing
HW
Harold W. DaviesNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$990K disclosed across 1 round · 2020
▶$990KraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$990KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brad FabbriDirector
- Michael HelmstetterExecutive Officer, Director
- Brett MorrisDirector
- Harold W. DaviesDirector
- Offering amount
- $990K
- Amount sold
- $990K
- First sale
- Jun 2020
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
GreenLight BiosciencesGreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.
Alnylam PharmaceuticalsAlnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
Companies working in the same space as RNAiSSANCE AG.
Frequently asked questions
- What does RNAiSSANCE AG do?
- RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research. The company focuses on discovery and production of RNA interference technology for crop protection.
- Who are RNAiSSANCE AG's investors?
- RNAiSSANCE AG's investors include Missouri Technology Corporation, Cultivation Capital.
- How much funding has RNAiSSANCE AG raised?
- RNAiSSANCE AG has disclosed $990K raised across 1 round.
- Where is RNAiSSANCE AG headquartered?
- RNAiSSANCE AG is headquartered in St. Louis, US.